Great report. Why are u bullshiting here? Company received US$255k after June 30 close and is expecting another US$400k during the next half. Other contracts will pour in cash and the covid testing ones pay 50% cash and then 50% after shipment so from Aug we should start seeing a nice pick up in cash flows
company has US$5m which is A$6.5m cash balance. I think combined with the coming cash flows in the next quarter or so and options congestion at the end of the year by SIBF and some of the Australian investors we should get another $1.5m. So I would expect min $then 8m cash balance by end of the year. That’s great and provides great working capital. As BB said if they managed to sign and really large deal which required cash to increase manufacturing capacity then they may need to look at some funding options but I guessey can always do a prepayment or something. We are on cheap boys. This is on the cusp of becoming much bigger. 60-70c by year end at least. I have been here since 8c guys this is not a 4-5x this will be multiple XX one day and I don’t plan to sell any shares before 2-3$ per share
- Forums
- ASX - By Stock
- DTZ
- Ann: Quarterly Report & Appendix 4C Cashflow Report - 30 June 21
Ann: Quarterly Report & Appendix 4C Cashflow Report - 30 June 21, page-4
Featured News
Add DTZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.7¢ |
Change
-0.004(4.40%) |
Mkt cap ! $47.21M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 7.5¢ | $5.687K | 67.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 74340 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.075 |
1 | 50000 | 0.072 |
1 | 91800 | 0.057 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 74340 | 1 |
0.090 | 50000 | 1 |
0.091 | 24000 | 1 |
0.092 | 102037 | 1 |
0.095 | 9999 | 1 |
Last trade - 14.15pm 12/11/2024 (20 minute delay) ? |
Featured News
DTZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online